Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection

Considerable differences exist amongst countries in the mutation probability methods and thresholds used to select patients for BRCA1/2 genetic screening. In order to assess the added value of mutation probability methods, we have retrospectively calculated the BRCAPRO and Myriad II probabilities in...

Descripción completa

Detalles Bibliográficos
Autores principales: van Harssel, J. J. T., van Roozendaal, C. E. P., Detisch, Y., Brandão, R. D., Paulussen, A. D. C., Zeegers, M., Blok, M. J., Gómez García, E. B.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871096/
https://www.ncbi.nlm.nih.gov/pubmed/19949876
http://dx.doi.org/10.1007/s10689-009-9305-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871096/
https://www.ncbi.nlm.nih.gov/pubmed/19949876
http://dx.doi.org/10.1007/s10689-009-9305-1

Ejemplares similares